We are live on
!
Find out more
Man Group Portfolio holdings
AUM
$55.1B
1-Year Est. Return
24.23%
This Fund
S&P 500
This Quarter
Est. Return
+9.93%
1 Year Est. Return
+24.23%
3 Year Est. Return
+82.67%
5 Year Est. Return
+105.49%
10 Year Est. Return
–
AUM
$30.4B
AUM Growth
+$3.48B
(+13%)
Cap. Flow
+$841M
Cap. Flow
% of AUM
2.77%
Top 10 Holdings %
Top 10 Hldgs %
10.11%
Holding
1,992
New
240
Increased
827
Reduced
644
Closed
177
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$151M |
| 2 |
Applied Materials
AMAT
|
+$145M |
| 3 |
Intuit
INTU
|
+$142M |
| 4 |
Humana
HUM
|
+$115M |
| 5 |
Sherwin-Williams
SHW
|
+$114M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Expedia Group
EXPE
|
+$177M |
| 2 |
Exelon
EXC
|
+$128M |
| 3 |
NXP Semiconductors
NXPI
|
+$124M |
| 4 |
UnitedHealth
UNH
|
+$119M |
| 5 |
PayPal
PYPL
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.39% |
| 2 | Healthcare | 14.41% |
| 3 | Financials | 14.4% |
| 4 | Consumer Discretionary | 11.94% |
| 5 | Industrials | 9.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
Akebia Therapeutics
AKBA
$327M
| $2.15M | 0.01% |
340,175
-25,172
| -7% | -$120K |
|
1252
OFG Bancorp
OFG
$2.21B
| $2.15M | 0.01% |
90,885
+15,350
| +20% | +$335K |
|
1253
Americold
COLD
$4.09B
| $2.13M | 0.01% |
60,900
-253,900
| -81% | -$9.34M |
|
1254
RLI Corp
RLI
$5.68B
| $2.13M | 0.01% |
47,422
-99,140
| -68% | -$4.66M |
|
1255
Bank of Hawaii
BOH
$3.33B
| $2.13M | 0.01% |
22,407
+469
| +2% | +$41.7K |
|
1256
Koppers
KOP
$966M
| $2.11M | 0.01% |
55,278
-3,700
| -6% | -$130K |
|
1257
iShares MSCI Indonesia ETF
EIDO
$476M
| $2.11M | 0.01% |
+82,264
| New | +$2.05M |
|
1258
Bright Horizons
BFAM
$3.99B
| $2.11M | 0.01% |
14,041
-18,891
| -57% | -$2.83M |
|
1259
DuPont de Nemours
DD
$18.6B
| $2.09M | 0.01% |
25,917
+14,021
| +118% | +$1.16M |
|
|
SGEN
1260
DELISTED
Seagen Inc. Common Stock
SGEN
| $2.07M | 0.01% |
+18,106
| New | +$1.92M |
|
|
NGHC
1261
DELISTED
National General Holdings Corp
NGHC
| $2.07M | 0.01% |
93,611
+8,000
| +9% | +$175K |
|
1262
Mueller Water Products
MWA
$3.92B
| $2.07M | 0.01% |
172,598
-66,447
| -28% | -$759K |
|
1263
CareDx
CDNA
$1.92B
| $2.06M | 0.01% |
+95,459
| New | +$2.19M |
|
1264
Fulton Financial
FULT
$4.7B
| $2.05M | 0.01% |
+117,827
| New | +$2M |
|
1265
Cartesian Therapeutics
RNAC
$232M
| $2.05M | 0.01% |
28,705
-92,418
| -76% | -$4.46M |
|
|
BMY.RT
1266
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $2.04M | 0.01% |
+677,537
| New | +$1.76M |
|
1267
New York Times
NYT
$11.6B
| $2.02M | 0.01% |
62,720
+7,310
| +13% | +$227K |
|
1268
Ulta Beauty
ULTA
$20.4B
| $2.01M | 0.01% |
7,955
-784
| -9% | -$192K |
|
1269
Zymeworks
ZYME
$1.68B
| $2.01M | 0.01% |
+44,294
| New | +$1.61M |
|
|
WORK
1270
DELISTED
Slack Technologies, Inc.
WORK
| $2.01M | 0.01% |
+89,254
| New | +$1.99M |
|
|
NTUS
1271
DELISTED
Natus Medical Inc
NTUS
| $2M | 0.01% |
+60,605
| New | +$1.94M |
|
|
JAX
1272
DELISTED
J. Alexander's Holdings, Inc.
JAX
| $1.99M | 0.01% |
207,930
-400
| -0.2% | -$4.04K |
|
|
DENN
1273
DELISTED
Denny's
DENN
| $1.97M | 0.01% |
99,096
+28,820
| +41% | +$594K |
|
1274
First Horizon
FHN
$12.1B
| $1.97M | 0.01% |
118,949
-8,953
| -7% | -$145K |
|
1275
Hackett Group
HCKT
$245M
| $1.95M | 0.01% |
120,654
+9,600
| +9% | +$153K |
|
Similar funds
Man Group's Q4 2019 Portfolio in Review
As of Q4 2019, Man Group held 1,992 positions worth $30.4B, up 13% from $26.9B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Man Group's Q4 2019 filing shows 240 new, 827 increased, 644 reduced and 177 closed positions. Its largest new stake was iShares MSCI Emerging Markets ETF: 1,207,475 shares worth $54.2M. The largest sale was Expedia Group, an estimated $177M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- Man Group's largest Q4 2019 buy was iShares MSCI Emerging Markets ETF: 1,207,475 shares worth $54.2M.
- Man Group added most to Procter & Gamble in Q4 2019, an estimated $151M increase.
- Man Group's biggest Q4 2019 reduction was Expedia Group, cutting an estimated $177M.
- Man Group fully exited Celgene Corp in Q4 2019, selling an estimated $47.9M.
- Man Group's ten largest holdings make up 10% of its $30.4B portfolio in Q4 2019.
- Man Group opened 240 new positions and closed 177 in Q4 2019.
- Man Group's portfolio value rose 13% quarter-over-quarter to $30.4B.
Based on Man Group's 13F filing for Q4 2019, filed 18 Feb 2020.